Business Novavax COVID shot is approved by FDA advisers, raising possibility of a fourth U.S. vaccine option Published 2 years ago on 06/07/2022 By Drew Simpson Next, the FDA must decide whether to authorize the protein vaccine made by latecomer Novavax as the nation’s fourth coronavirus shot for adults. Read More Related Topics:advisersapprovedCOVIDfdafourthNovavaxoptionpossibilityraisingshotvaccine